182 related articles for article (PubMed ID: 23136963)
1. Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor.
Chiang HC; Wang YS; Chou CH; Liao AT; Chu RM; Lin CS
BMC Vet Res; 2012 Nov; 8():216. PubMed ID: 23136963
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
Hsiao YW; Liao KW; Hung SW; Chu RM
Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity.
Hsiao YW; Liao KW; Hung SW; Chu RM
J Immunol; 2004 Feb; 172(3):1508-14. PubMed ID: 14734728
[TBL] [Abstract][Full Text] [Related]
4. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
Hsiao YW; Liao KW; Chung TF; Liu CH; Hsu CD; Chu RM
Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
[TBL] [Abstract][Full Text] [Related]
5. Canine CXCL7 and its functional expression in dendritic cells undergoing maturation.
Wang YS; Liao KW; Chen MF; Huang YC; Chu RM; Chi KH
Vet Immunol Immunopathol; 2010 May; 135(1-2):128-136. PubMed ID: 20022386
[TBL] [Abstract][Full Text] [Related]
6. Gene-expression profiling to identify genes related to spontaneous tumor regression in a canine cancer model.
Chiang HC; Liao AT; Jan TR; Wang YS; Lei HJ; Tsai MH; Chen MF; Lee CY; Lin YC; Chu RM; Lin CS
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):207-16. PubMed ID: 23237908
[TBL] [Abstract][Full Text] [Related]
7. Stromal cells and extracellular matrix components in spontaneous canine transmissible venereal tumour at different stages of growth.
Mukaratirwa S; Chimonyo M; Obwolo M; Gruys E; Nederbragt H
Histol Histopathol; 2004 Oct; 19(4):1117-23. PubMed ID: 15375754
[TBL] [Abstract][Full Text] [Related]
8. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
[TBL] [Abstract][Full Text] [Related]
9. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
[TBL] [Abstract][Full Text] [Related]
10. TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor.
Sánchez-Servín A; Martínez S; Córdova-Alarcon E; Fajardo R
J Vet Sci; 2009 Dec; 10(4):353-5. PubMed ID: 19934603
[TBL] [Abstract][Full Text] [Related]
11. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
[TBL] [Abstract][Full Text] [Related]
12. Detection of progressive and regressive phase and LINE-1 retrotransposon in transfected dogs with transmissible venereal tumor during chemotherapy.
Vural SA; Haziroglu R; Vural MR; Polat IM; Tunc AS
J Vet Sci; 2018 Sep; 19(5):620-626. PubMed ID: 30041285
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial capture by a transmissible cancer.
Rebbeck CA; Leroi AM; Burt A
Science; 2011 Jan; 331(6015):303. PubMed ID: 21252340
[TBL] [Abstract][Full Text] [Related]
14. Canine transmissible venereal tumour: assessment of mast cell numbers as indicators of the growth phase.
Mukaratirwa S; Chiwome T; Chitanga S; Bhebhe E
Vet Res Commun; 2006 Aug; 30(6):613-21. PubMed ID: 16838203
[TBL] [Abstract][Full Text] [Related]
15. Identification of mitochondrial DNA transfer in canine transmissible venereal tumours obtained from dogs in Mexico.
Bautista-Gómez L; Martínez-Castañeda S
Mitochondrial DNA A DNA Mapp Seq Anal; 2017 Sep; 28(5):645-649. PubMed ID: 27159723
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical characterization of canine transmissible venereal tumor.
Mozos E; Méndez A; Gómez-Villamandos JC; Martín De Las Mulas J; Pérez J
Vet Pathol; 1996 May; 33(3):257-63. PubMed ID: 8740698
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT?
do Prado Duzanski A; Flórez LMM; Fêo HB; Romagnoli GG; Kaneno R; Rocha NS
Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476
[TBL] [Abstract][Full Text] [Related]
18. Extensive conservation of genomic imbalances in canine transmissible venereal tumors (CTVT) detected by microarray-based CGH analysis.
Thomas R; Rebbeck C; Leroi AM; Burt A; Breen M
Chromosome Res; 2009; 17(7):927-34. PubMed ID: 19798471
[TBL] [Abstract][Full Text] [Related]
19. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil.
Castro KF; Strakova A; Tinucci-Costa M; Murchison EP
Vet Comp Oncol; 2017 Jun; 15(2):615-618. PubMed ID: 27135875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
